Brief summary describing the background
and objectives of the trial
|
Type 2 Diabetes mellitus is a major global public health concern (IDF; International DiabetesFederation, 2017; The International Diabetes Federation (IDF), 2015; WHO; World Health Organization, 2016, 2017). In 2016, there were 415 million people affected while in 2017 there were425 million people were affected (IDF; International DiabetesFederation, 2017; The International Diabetes Federation (IDF), 2015). It is projected that by 2045, there will be 629 million people living with Diabetes (IDF; International DiabetesFederation, 2017) Statistics have also shown that 80% of the people with Type 2 Diabetes come from low and middle income countries (IDF; International DiabetesFederation, 2017; WHO; World Health Organization, 2016, 2017)Diabetes is a threat to national development as it often results in longstanding complications like blindness, renal failure and lower limb amputation that are usually very costly to treat(IDF; International DiabetesFederation, 2017; WHO; World Health Organization, 2016). In addition, a high percentage of undiagnosed diabetes ends up in irreversible medical conditions thus posing a bigger challenge to this burden(IDF; International DiabetesFederation, 2017). Several modifiable factors that are risk factors to diabetes include obesity/overweight, consumption of refined carbohydrates, consumption of high fat diets and lack of physical activity due to sedentary lifestyle (Chiu & Wray, 2010; Hu, Hori, Nishiura, Sasaki, & Okazaki, 2016; IDF; International DiabetesFederation, 2017; Little, Humphries, Patel, & Dewey, 2016; Tadewos, Egeno, & Amsalu, 2017)These risk factors are also related to metabolic syndrome; a cluster of interrelated clinical factors that include insulin resistance, dyslipidemia, excess weight and elevated blood pressure(Alberti K.G.M.M. et al., 2009)Metabolic syndrome is associated with a threefold increase in Type 2-diabetes and a two fold increase in cardiovascular diseases (Alberti K.G.M.M. et al., 2009; Kaur, 2014)In addition, lack of adherence by patient to diet, physical activity and other lifestyle conditions as well as reaction to drugs aggravate the condition (Alefishat & Farha, 2017; Ganiyu, Mabuza, Malete, Govender, & Ogunbanjo, 2013; Mukonka, Mukona, Zvinavashe, Augustine, & Maxwell, 2016; Musee, Omondi, & Odiwuor, 2016; Riaz, Basit, Fawwad, Ahmedani, & Riizv, 2014)).
Coordinated interventions that encourage individuals to maintain healthy weight, have good controlled glucose level and participate in physical activity can reduce the negative effects of Diabetes as well as metabolic syndrome (Anderson et al., 2015; Askari, Rabiei, & Rastmanesh, 2013; A. M. et al., 2013; Makrilakis et al., 2012; Mohamed, 2014; Muchiri, Gericke, & Rheeder, 2015; Soósová & Hrehová, 2014; Yamaoka & Tango, 2012). This study aim was to test the effectiveness of a nutrition education programme on nutrition and physical activity knowledge, metabolic syndrome, adherence to lifestyle changes and health care cost incurred by Type 2 Diabetes patient’s mellitus. This was a randomized controlled trial with two intervention groups and one control. |